Digital Commons @ Winthrop University - Showcase of Undergraduate Research and Creative Endeavors (SOURCE): The Synthesis of Diarylpyridines as Inhibitors of Amyloid Beta Aggregation for Alzheimer’s Disease

 

The Synthesis of Diarylpyridines as Inhibitors of Amyloid Beta Aggregation for Alzheimer’s Disease

Submitting Student(s)

Casey Kopyc
Mary Stegall-Smith

Session Title

Poster Session 1

Faculty Mentor

Robin K. Lammi, Ph.D.| James M. Hanna Jr., Ph.D.

College

College of Arts and Sciences

Department

Chemistry, Physics, Geology, & the Environment

Abstract

Amyloid-beta (A-beta) is a peptide which aggregates with other A-beta chains in the brain to form plaques which are correlated to the progression of Alzheimer’s Disease (AD). The amino acid phenylalanine plays a key role in aggregation through π-stacking interactions. Previous research in our group has shown that hydrogen bond donors on a biphenyl or terphenyl system can effectively inhibit aggregation, as well as those with a central phenyl linker region. To test how differences in the pi-stacking ability in an inhibitor affect aggregation, molecules with a central pyridine linker region, diphenylpyridinetetrol (DPPT) derivatives, were synthesized through Suzuki-Miyaura coupling followed by demethylation with hydrobromic acid (48% aq). Once the small molecules were synthesized, a Congo Red (CR) assay was performed on A-beta(40) to obtain data regarding the efficacy of inhibition. Products were synthesized in a wide range of yields, and preliminary CR assays showed possible inhibitory effects of some derivatives.

Previously Presented/Performed?

INBRE Science Symposium, Columbia, SC, February 2023 | Winthrop University Showcase of Undergraduate Research and Creative Endeavors, Rock Hill, SC, April 2023

Type of Presentation

Poster presentation

Grant Support?

Supported by an SC-INBRE grant from the National Institute for General Medical Sciences (P20GM103499).

Start Date

15-4-2023 12:00 PM

This document is currently not available here.

Share

COinS
 
Apr 15th, 12:00 PM

The Synthesis of Diarylpyridines as Inhibitors of Amyloid Beta Aggregation for Alzheimer’s Disease

Amyloid-beta (A-beta) is a peptide which aggregates with other A-beta chains in the brain to form plaques which are correlated to the progression of Alzheimer’s Disease (AD). The amino acid phenylalanine plays a key role in aggregation through π-stacking interactions. Previous research in our group has shown that hydrogen bond donors on a biphenyl or terphenyl system can effectively inhibit aggregation, as well as those with a central phenyl linker region. To test how differences in the pi-stacking ability in an inhibitor affect aggregation, molecules with a central pyridine linker region, diphenylpyridinetetrol (DPPT) derivatives, were synthesized through Suzuki-Miyaura coupling followed by demethylation with hydrobromic acid (48% aq). Once the small molecules were synthesized, a Congo Red (CR) assay was performed on A-beta(40) to obtain data regarding the efficacy of inhibition. Products were synthesized in a wide range of yields, and preliminary CR assays showed possible inhibitory effects of some derivatives.